Lidocaine 1:100M Anaesthetic 50/Bx (Red)
This anesthetic solution combines Lidocaine Hydrochloride with Epinephrine (as bitartrate) in a sterile isotonic formula designed for parenteral injection. It delivers effective local anesthesia while minimizing bleeding through vasoconstriction.

• Lidocaine concentration optimized for rapid onset and moderate duration
• Epinephrine ratio of 1:100,000 for controlled vasoconstriction
• Sterile isotonic solution for safe parenteral administration
• Supplied in packs of 50 units for efficient clinical use
• Packaged with red coding for quick identification

Compared to other anesthetic options on the market, Lidocaine 1:100M Anaesthetic 50/Bx (Red) offers a balanced epinephrine concentration that provides sufficient blood vessel constriction without compromising patient comfort. While higher concentrations of epinephrine exist, this formula reduces systemic side effects and extends the anesthetic effect well beyond plain Lidocaine solutions. In comparison to previous models containing 1:50,000 epinephrine, the 1:100,000 ratio is ideal for procedures requiring moderate bleeding control with enhanced safety.

Key Technical Advantages:

• Precise combination of Lidocaine and Epinephrine enhances anesthetic efficiency while controlling local bleeding
• Sterile isotonic solution ensures patient safety and reduces tissue irritation
• Convenient packaging improves workflow and decreases the risk of dosing errors

Technology and Performance
The formulation utilizes Lidocaine Hydrochloride’s rapid onset to numb targeted areas effectively, while the presence of Epinephrine constricts blood vessels to limit bleeding and prolong anesthetic effects. This dual-action technology results in improved patient experience and procedural success across various medical and dental applications. The iso-osmotic environment of the solution ensures compatibility with bodily tissues, reducing discomfort upon injection. Overall, this anesthetic solution meets high clinical standards for safety, efficacy, and usability.